Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial (Q33584895)

28 July 2017

Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial (English)

1 reference

28 July 2017

1 reference

1 reference

Farsad Eskandary

1

0 references

Gregor Bartel

Gregor Bond

2

0 references

Markus Wahrmann

Markus Wahrmann

6

0 references

Helmuth Haslacher

Helmuth Haslacher

8

0 references

Elisabeth Schwaiger

3

Elisabeth Schwaiger

1 reference

28 July 2017

4

Zeljko Kikic

1 reference

28 July 2017

7

Lena Marinova

1 reference

28 July 2017

10

Rainer Oberbauer

1 reference

28 July 2017

11

Georg A Böhmig

1 reference

28 July 2017

Christine Winzer

5

1 reference

PubMed ID

24708575

28 July 2017

Heinz Regele

9

1 reference

28 July 2017

3 April 2014

1 reference

28 July 2017

1 reference

28 July 2017

15

1 reference

28 July 2017

107

1 reference

https://scigraph.springernature.com/pub.10.1186/1745-6215-15-107

28 July 2017

0 references

cites work

Proteasome inhibitor-based therapy for antibody-mediated rejection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014747

Banff 2011 Meeting report: new concepts in antibody-mediated rejection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014747

Prevention and treatment of alloantibody-mediated kidney transplant rejection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014747

Reduction in proteinuria with bortezomib based therapy for antibody mediated rejection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014747

Bortezomib for the treatment of chronic antibody-mediated kidney allograft rejection: a case report.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014747

The pathology of chronic allograft dysfunction

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014747

Long-term renal allograft survival in the United States: a critical reappraisal

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014747

A summary of bortezomib use in transplantation across 29 centers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014747

Bortezomib and sirolimus inhibit the chronic active antibody-mediated rejection in experimental renal transplantation in the rat.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014747

Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014747

Proteasome inhibition for antibody-mediated rejection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014747

Review article: Luminex technology for HLA antibody detection in organ transplantation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014747

Antibody-mediated renal allograft rejection: diagnosis and pathogenesis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014747

Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014747

Humoral theory of transplantation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014747

Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014747

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-15-107

Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-15-107

Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-15-107

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-15-107

Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-15-107

The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-15-107

Dampening Ab responses using proteasome inhibitors following in vivo B cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-15-107

Interim analysis: the alpha spending function approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-15-107

Post-transplant renal function in the first year predicts long-term kidney transplant survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-15-107

Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014747

Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014747

Two novel assays of alloantibody-secreting cells demonstrating resistance to desensitization with IVIG and rATG.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014747

Successful treatment of chronic antibody-mediated rejection with IVIG and rituximab in pediatric renal transplant recipients

31 October 2018

1 reference

12 December 2020

De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure

1 reference

12 December 2020

Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients

1 reference

12 December 2020

Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence

1 reference

12 December 2020

IVIG and rituximab for treatment of chronic antibody-mediated rejection: a prospective study in paediatric renal transplantation with a 2-year follow-up

1 reference

12 December 2020

Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection

1 reference

12 December 2020

All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies

1 reference

12 December 2020

Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies?

1 reference

12 December 2020

Intravenous immunoglobulin treatment in a kidney transplant patient with chronic allograft nephropathy

1 reference

12 December 2020

Immunoadsorption in severe C4d-positive acute kidney allograft rejection: a randomized controlled trial

1 reference

12 December 2020

Assessment of changes in kidney allograft function using creatinine-based estimates of glomerular filtration rate

1 reference

12 December 2020

Identifiers

DOI

10.1186/1745-6215-15-107

1 reference

PubMed ID

24708575

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference

PubMed ID

24708575